nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—SLC22A8—Furosemide—dilated cardiomyopathy	0.357	0.508	CbGbCtD
Ranitidine—ABCB1—Lisinopril—dilated cardiomyopathy	0.184	0.262	CbGbCtD
Ranitidine—ABCB1—Spironolactone—dilated cardiomyopathy	0.162	0.231	CbGbCtD
Ranitidine—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.0115	0.04	CcSEcCtD
Ranitidine—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00896	0.0311	CcSEcCtD
Ranitidine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00779	0.0271	CcSEcCtD
Ranitidine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0068	0.0236	CcSEcCtD
Ranitidine—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0054	0.0188	CcSEcCtD
Ranitidine—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00505	0.0175	CcSEcCtD
Ranitidine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00472	0.0164	CcSEcCtD
Ranitidine—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00471	0.0163	CcSEcCtD
Ranitidine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.0046	0.016	CcSEcCtD
Ranitidine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00439	0.0153	CcSEcCtD
Ranitidine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00424	0.0147	CcSEcCtD
Ranitidine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00397	0.0138	CcSEcCtD
Ranitidine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00388	0.0135	CcSEcCtD
Ranitidine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0037	0.0129	CcSEcCtD
Ranitidine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00361	0.0125	CcSEcCtD
Ranitidine—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00353	0.0123	CcSEcCtD
Ranitidine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00344	0.0119	CcSEcCtD
Ranitidine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00342	0.0119	CcSEcCtD
Ranitidine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00337	0.0117	CcSEcCtD
Ranitidine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00318	0.011	CcSEcCtD
Ranitidine—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00314	0.0109	CcSEcCtD
Ranitidine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00308	0.0107	CcSEcCtD
Ranitidine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00301	0.0105	CcSEcCtD
Ranitidine—Malaise—Spironolactone—dilated cardiomyopathy	0.003	0.0104	CcSEcCtD
Ranitidine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00298	0.0103	CcSEcCtD
Ranitidine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00281	0.00977	CcSEcCtD
Ranitidine—Discomfort—Spironolactone—dilated cardiomyopathy	0.0028	0.00971	CcSEcCtD
Ranitidine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00278	0.00964	CcSEcCtD
Ranitidine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00274	0.0095	CcSEcCtD
Ranitidine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00271	0.00942	CcSEcCtD
Ranitidine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00266	0.00922	CcSEcCtD
Ranitidine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00257	0.00892	CcSEcCtD
Ranitidine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00257	0.00891	CcSEcCtD
Ranitidine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00255	0.00884	CcSEcCtD
Ranitidine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00251	0.00871	CcSEcCtD
Ranitidine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00241	0.00837	CcSEcCtD
Ranitidine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00237	0.00823	CcSEcCtD
Ranitidine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00224	0.00776	CcSEcCtD
Ranitidine—Sweating—Furosemide—dilated cardiomyopathy	0.00222	0.0077	CcSEcCtD
Ranitidine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00216	0.0075	CcSEcCtD
Ranitidine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00216	0.00748	CcSEcCtD
Ranitidine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00214	0.00745	CcSEcCtD
Ranitidine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00214	0.00744	CcSEcCtD
Ranitidine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00211	0.00733	CcSEcCtD
Ranitidine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00204	0.00707	CcSEcCtD
Ranitidine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.002	0.00694	CcSEcCtD
Ranitidine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00196	0.00682	CcSEcCtD
Ranitidine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00193	0.00669	CcSEcCtD
Ranitidine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00192	0.00666	CcSEcCtD
Ranitidine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00192	0.00665	CcSEcCtD
Ranitidine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00191	0.00663	CcSEcCtD
Ranitidine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.0019	0.00659	CcSEcCtD
Ranitidine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00186	0.00644	CcSEcCtD
Ranitidine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00186	0.00644	CcSEcCtD
Ranitidine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00185	0.00642	CcSEcCtD
Ranitidine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00182	0.00632	CcSEcCtD
Ranitidine—Erythema—Furosemide—dilated cardiomyopathy	0.00181	0.00628	CcSEcCtD
Ranitidine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00179	0.00623	CcSEcCtD
Ranitidine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00179	0.00623	CcSEcCtD
Ranitidine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00178	0.00617	CcSEcCtD
Ranitidine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00176	0.00612	CcSEcCtD
Ranitidine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00175	0.00606	CcSEcCtD
Ranitidine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00173	0.00599	CcSEcCtD
Ranitidine—Rash—Spironolactone—dilated cardiomyopathy	0.00171	0.00594	CcSEcCtD
Ranitidine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00171	0.00593	CcSEcCtD
Ranitidine—Vision blurred—Furosemide—dilated cardiomyopathy	0.0017	0.00592	CcSEcCtD
Ranitidine—Headache—Spironolactone—dilated cardiomyopathy	0.0017	0.0059	CcSEcCtD
Ranitidine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00169	0.00588	CcSEcCtD
Ranitidine—Anaemia—Furosemide—dilated cardiomyopathy	0.00167	0.0058	CcSEcCtD
Ranitidine—Sweating—Lisinopril—dilated cardiomyopathy	0.00166	0.00578	CcSEcCtD
Ranitidine—Agitation—Furosemide—dilated cardiomyopathy	0.00166	0.00577	CcSEcCtD
Ranitidine—Vertigo—Furosemide—dilated cardiomyopathy	0.00163	0.00564	CcSEcCtD
Ranitidine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00162	0.00563	CcSEcCtD
Ranitidine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00162	0.00562	CcSEcCtD
Ranitidine—Nausea—Spironolactone—dilated cardiomyopathy	0.00161	0.00559	CcSEcCtD
Ranitidine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00159	0.00551	CcSEcCtD
Ranitidine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00156	0.00541	CcSEcCtD
Ranitidine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00155	0.00538	CcSEcCtD
Ranitidine—Confusional state—Furosemide—dilated cardiomyopathy	0.00149	0.00517	CcSEcCtD
Ranitidine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00148	0.00512	CcSEcCtD
Ranitidine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00147	0.00512	CcSEcCtD
Ranitidine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00145	0.00502	CcSEcCtD
Ranitidine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00143	0.00495	CcSEcCtD
Ranitidine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00139	0.00483	CcSEcCtD
Ranitidine—Hypotension—Furosemide—dilated cardiomyopathy	0.00138	0.00479	CcSEcCtD
Ranitidine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00138	0.00478	CcSEcCtD
Ranitidine—Erythema—Lisinopril—dilated cardiomyopathy	0.00136	0.00471	CcSEcCtD
Ranitidine—Somnolence—Furosemide—dilated cardiomyopathy	0.00131	0.00456	CcSEcCtD
Ranitidine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00128	0.00444	CcSEcCtD
Ranitidine—Pain—Furosemide—dilated cardiomyopathy	0.00126	0.00438	CcSEcCtD
Ranitidine—Constipation—Furosemide—dilated cardiomyopathy	0.00126	0.00438	CcSEcCtD
Ranitidine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00126	0.00437	CcSEcCtD
Ranitidine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00125	0.00435	CcSEcCtD
Ranitidine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00124	0.0043	CcSEcCtD
Ranitidine—Malaise—Lisinopril—dilated cardiomyopathy	0.00122	0.00425	CcSEcCtD
Ranitidine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00122	0.00423	CcSEcCtD
Ranitidine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00122	0.00422	CcSEcCtD
Ranitidine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00121	0.00422	CcSEcCtD
Ranitidine—Urticaria—Furosemide—dilated cardiomyopathy	0.00117	0.00407	CcSEcCtD
Ranitidine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00117	0.00405	CcSEcCtD
Ranitidine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00117	0.00405	CcSEcCtD
Ranitidine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00116	0.00401	CcSEcCtD
Ranitidine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00116	0.00401	CcSEcCtD
Ranitidine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00116	0.00401	CcSEcCtD
Ranitidine—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00114	0.135	CbGpPWpGaD
Ranitidine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00114	0.00396	CcSEcCtD
Ranitidine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00112	0.00388	CcSEcCtD
Ranitidine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00111	0.00384	CcSEcCtD
Ranitidine—SLC22A1—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00109	0.129	CbGpPWpGaD
Ranitidine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00109	0.00378	CcSEcCtD
Ranitidine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00108	0.00376	CcSEcCtD
Ranitidine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00108	0.00375	CcSEcCtD
Ranitidine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00107	0.00372	CcSEcCtD
Ranitidine—Pruritus—Furosemide—dilated cardiomyopathy	0.00104	0.00363	CcSEcCtD
Ranitidine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00103	0.00359	CcSEcCtD
Ranitidine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00101	0.00351	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00101	0.0035	CcSEcCtD
Ranitidine—Insomnia—Lisinopril—dilated cardiomyopathy	0.001	0.00348	CcSEcCtD
Ranitidine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000987	0.00343	CcSEcCtD
Ranitidine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000985	0.00342	CcSEcCtD
Ranitidine—Dizziness—Furosemide—dilated cardiomyopathy	0.000976	0.00339	CcSEcCtD
Ranitidine—Constipation—Lisinopril—dilated cardiomyopathy	0.000947	0.00329	CcSEcCtD
Ranitidine—Pain—Lisinopril—dilated cardiomyopathy	0.000947	0.00329	CcSEcCtD
Ranitidine—Vomiting—Furosemide—dilated cardiomyopathy	0.000939	0.00326	CcSEcCtD
Ranitidine—Rash—Furosemide—dilated cardiomyopathy	0.000931	0.00323	CcSEcCtD
Ranitidine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00093	0.00323	CcSEcCtD
Ranitidine—Headache—Furosemide—dilated cardiomyopathy	0.000925	0.00321	CcSEcCtD
Ranitidine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000913	0.00317	CcSEcCtD
Ranitidine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00088	0.00305	CcSEcCtD
Ranitidine—Nausea—Furosemide—dilated cardiomyopathy	0.000877	0.00304	CcSEcCtD
Ranitidine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000876	0.00304	CcSEcCtD
Ranitidine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000876	0.00304	CcSEcCtD
Ranitidine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000816	0.00283	CcSEcCtD
Ranitidine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000784	0.00272	CcSEcCtD
Ranitidine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000758	0.00263	CcSEcCtD
Ranitidine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000741	0.0873	CbGpPWpGaD
Ranitidine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000732	0.00254	CcSEcCtD
Ranitidine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000704	0.00244	CcSEcCtD
Ranitidine—Rash—Lisinopril—dilated cardiomyopathy	0.000698	0.00242	CcSEcCtD
Ranitidine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000698	0.00242	CcSEcCtD
Ranitidine—Headache—Lisinopril—dilated cardiomyopathy	0.000694	0.00241	CcSEcCtD
Ranitidine—Nausea—Lisinopril—dilated cardiomyopathy	0.000658	0.00228	CcSEcCtD
Ranitidine—HRH2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000325	0.0382	CbGpPWpGaD
Ranitidine—HRH2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000273	0.0322	CbGpPWpGaD
Ranitidine—HRH2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000263	0.031	CbGpPWpGaD
Ranitidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000229	0.027	CbGpPWpGaD
Ranitidine—HRH2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000221	0.026	CbGpPWpGaD
Ranitidine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000179	0.021	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000166	0.0195	CbGpPWpGaD
Ranitidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000148	0.0175	CbGpPWpGaD
Ranitidine—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000114	0.0134	CbGpPWpGaD
Ranitidine—HRH2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000113	0.0133	CbGpPWpGaD
Ranitidine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000105	0.0123	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000104	0.0122	CbGpPWpGaD
Ranitidine—HRH2—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	9.12e-05	0.0107	CbGpPWpGaD
Ranitidine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	8.87e-05	0.0104	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	7.41e-05	0.00873	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	6.96e-05	0.0082	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	6.74e-05	0.00794	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	6.47e-05	0.00762	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	6.27e-05	0.00738	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	5.96e-05	0.00702	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	5.96e-05	0.00702	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	5.92e-05	0.00698	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	5.68e-05	0.00669	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	5.54e-05	0.00653	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.43e-05	0.0064	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	5.37e-05	0.00632	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	5.35e-05	0.0063	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.28e-05	0.00622	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.28e-05	0.00622	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	5.08e-05	0.00598	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	5.06e-05	0.00596	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.05e-05	0.00594	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.91e-05	0.00579	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	4.59e-05	0.0054	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	4.54e-05	0.00535	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	4.54e-05	0.00535	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	4.35e-05	0.00512	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	4.26e-05	0.00501	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.22e-05	0.00497	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	4.09e-05	0.00482	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.09e-05	0.00482	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	3.93e-05	0.00463	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	3.57e-05	0.0042	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.52e-05	0.00415	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	3.49e-05	0.00411	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.43e-05	0.00404	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.43e-05	0.00404	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	3.32e-05	0.00391	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.31e-05	0.0039	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.23e-05	0.0038	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.2e-05	0.00377	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.19e-05	0.00375	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.12e-05	0.00368	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.94e-05	0.00346	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.57e-05	0.00302	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.57e-05	0.00302	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	2.56e-05	0.00301	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—AGT—dilated cardiomyopathy	2.46e-05	0.00289	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.43e-05	0.00287	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.39e-05	0.00281	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.33e-05	0.00274	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.33e-05	0.00274	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.32e-05	0.00273	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.31e-05	0.00272	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.29e-05	0.00269	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	2.18e-05	0.00256	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.17e-05	0.00255	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.1e-05	0.00247	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.06e-05	0.00243	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.01e-05	0.00237	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.01e-05	0.00237	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.97e-05	0.00232	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	1.97e-05	0.00232	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.87e-05	0.0022	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.87e-05	0.0022	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	1.8e-05	0.00212	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.79e-05	0.00211	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	1.75e-05	0.00207	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	1.75e-05	0.00207	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.7e-05	0.002	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	1.69e-05	0.00199	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.69e-05	0.00199	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	1.67e-05	0.00197	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	1.67e-05	0.00197	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.64e-05	0.00193	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.58e-05	0.00186	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.55e-05	0.00183	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.55e-05	0.00182	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	1.53e-05	0.0018	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.45e-05	0.00171	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.39e-05	0.00164	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.39e-05	0.00164	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.38e-05	0.00162	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.38e-05	0.00162	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.36e-05	0.0016	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.36e-05	0.0016	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.32e-05	0.00155	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.31e-05	0.00154	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	1.29e-05	0.00152	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.28e-05	0.00151	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.28e-05	0.00151	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.28e-05	0.0015	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.26e-05	0.00149	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.24e-05	0.00146	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.2e-05	0.00142	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.18e-05	0.00139	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.15e-05	0.00136	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.09e-05	0.00128	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.08e-05	0.00128	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.07e-05	0.00126	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.06e-05	0.00125	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.03e-05	0.00121	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.02e-05	0.0012	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1e-05	0.00118	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	9.21e-06	0.00109	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.75e-06	0.00103	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.63e-06	0.00102	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	8.36e-06	0.000985	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.86e-06	0.000926	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.8e-06	0.000918	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AGT—dilated cardiomyopathy	7.45e-06	0.000877	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.21e-06	0.000849	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.11e-06	0.000837	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.03e-06	0.000829	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.02e-06	0.000827	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.95e-06	0.000818	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.7e-06	0.000789	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.32e-06	0.000745	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6e-06	0.000707	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.62e-06	0.000662	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.47e-06	0.000645	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	5.35e-06	0.00063	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	5.21e-06	0.000613	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.17e-06	0.000609	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.93e-06	0.00058	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	4.69e-06	0.000552	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	4.15e-06	0.000489	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.07e-06	0.00048	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.05e-06	0.000477	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	3.64e-06	0.000429	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.54e-06	0.000418	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.21e-06	0.000378	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.13e-06	0.000369	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.13e-06	0.000368	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.05e-06	0.00036	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.95e-06	0.000348	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.88e-06	0.000339	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.82e-06	0.000332	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.75e-06	0.000324	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.59e-06	0.000305	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.5e-06	0.000295	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.44e-06	0.000287	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.19e-06	0.000258	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.93e-06	0.000227	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.88e-06	0.000222	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.69e-06	0.000199	CbGpPWpGaD
